NCT07603791
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Clinical trial condition
NSCLC (Advanced Non-small Cell Lung Cancer)
Explore clinical trials studying NSCLC (Advanced Non-small Cell Lung Cancer). Study availability and eligibility vary by location and protocol.
51 public trials
25 recruiting studies
NSCLC (Advanced Non-small Cell Lung Cancer) trial results
Not Yet Recruiting
Adebrelimab Combined With Chemoradiotherapy in Patients With Large Bulky Stage III Unresectable Non-Small Cell Lung Cancer
NCT07560358
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
Not Yet Recruiting
Overcoming Resistance to Immunotherapy Combining Gemcitabine With Ivonescimab in Advanced NSCLC
NCT07158489
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Kantonsspital Baden Baden, Switzerland
- Universitätsspital Basel Basel, Switzerland
- IOSI Ospedale Regionale di Bellinzona e Valli Bellinzona, Switzerland
- Kantonsspital Graubuenden Chur, Switzerland
NCT07469488
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
- Locations
-
- Shanghai Pulmonary Hospital Shanghai, China
Not Yet Recruiting
FANLUNG-2：The Value of High-Low Mixed-Dose Radiotherapy Combined With Chemo-Immunotherapy Induction in Locally Advanced Non-Small Cell Lung Cancer
NCT07418866
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Not Yet Recruiting
Anlotinib in Cross-line Treatment of NSCLC and SCLC
NCT07400575
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC
NCT07353476
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
Not specified
Not Yet Recruiting
Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases
NCT07343479
- Conditions
- Brain Diseases, Brain Metastasis, Brain Neoplasms, +16 more
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Not Yet Recruiting
Immune-Marker Platform for Patients With Advanced Lung Cancer
NCT07150598
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO) Köln Cologne, North Rhine-Westphalia, Germany
- Universitätsklinikum Carl Gustav Carus Dresden, Saxony, Germany
Not Yet Recruiting
Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer
NCT06951399
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Davidoff Comprehensive Cancer Center, Rabin Medical Center Petah Tikva, Israel